$CMAXQ
CareMax, Inc. Stock $cmaxq

$cmaxq Overview Financials Valuation SEC Filings Company Website

2022 Q4 Form 10-K Financial Statement

#000095017023011018 Filed on March 30, 2023

Income Statement

Concept	2022 Q4	2022
Revenue	$164.3M	$631.1M
YoY Change	38.85%	113.39%
Cost Of Revenue	$142.8M	$550.8M
YoY Change	39.36%	108.4%
Gross Profit	$21.46M	$80.30M
YoY Change	35.51%	155.34%
Gross Profit Margin	13.07%	12.72%
Selling, General & Admin	$20.90M	$87.59M
YoY Change	10.42%	92.35%
% of Gross Profit	97.39%	109.07%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$7.181M	$21.72M
YoY Change	18.3%	675.68%
% of Gross Profit	33.46%	27.05%
Operating Expenses	$28.08M	$109.3M
YoY Change	12.24%	-66.33%
Operating Profit	-$6.619M	-$29.00M
YoY Change	-27.91%	0.62%
Interest Expense	-$665.0K	-$15.84M
YoY Change	-109.74%	252.65%
% of Operating Profit
Other Income/Expense, Net	$966.0K	$546.0K
YoY Change	-295.15%	-140.96%
Pretax Income	-$9.639M	-$57.34M
YoY Change	183.75%	779.94%
Income Tax	-$20.07M	-$19.54M
% Of Pretax Income
Net Earnings	$10.43M	-$37.80M
YoY Change	-393.42%	466.23%
Net Earnings / Revenue	6.35%	-5.99%
Basic Earnings Per Share		-$0.42
Diluted Earnings Per Share	$0.10	-$0.42
COMMON SHARES
Basic Shares Outstanding		90.80M
Diluted Shares Outstanding		90.80M

Balance Sheet

Concept	2022 Q4	2022
SHORT-TERM ASSETS
Cash & Short-Term Investments	$41.63M	$41.63M
YoY Change	-13.13%	-13.13%
Cash & Equivalents	$41.63M
Short-Term Investments
Other Short-Term Assets	$3.951M	$3.951M
YoY Change	-77.52%	-77.52%
Inventory	$723.0K	$723.0K
Prepaid Expenses
Receivables	$151.0M	$151.0M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$197.3M	$197.3M
YoY Change	82.64%	82.64%
LONG-TERM ASSETS
Property, Plant & Equipment	$129.9M	$129.9M
YoY Change	712.5%	712.5%
Goodwill	$700.6M
YoY Change	50.82%
Intangibles	$123.6M
YoY Change	106.63%
Long-Term Investments
YoY Change
Other Assets	$19.24M	$19.24M
YoY Change	610.86%	311.2%
Total Long-Term Assets	$973.4M	$973.4M
YoY Change	78.59%	78.59%
TOTAL ASSETS
Total Short-Term Assets	$197.3M	$197.3M
Total Long-Term Assets	$973.4M	$973.4M
Total Assets	$1.171B	$1.171B
YoY Change	79.26%	79.26%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$7.687M	$7.687M
YoY Change	147.17%	147.17%
Accrued Expenses	$24.14M	$24.14M
YoY Change	177.83%	177.83%
Deferred Revenue
YoY Change
Short-Term Debt	$30.28M	$30.28M
YoY Change
Long-Term Debt Due	$253.0K	$253.0K
YoY Change	-95.97%	-95.97%
Total Short-Term Liabilities	$77.32M	$77.32M
YoY Change	252.12%	252.12%
LONG-TERM LIABILITIES
Long-Term Debt	$230.7M	$230.7M
YoY Change	107.94%	107.94%
Other Long-Term Liabilities	$243.1M	$243.1M
YoY Change	3682.65%	1542.57%
Total Long-Term Liabilities	$473.9M	$473.9M
YoY Change	303.68%	276.8%
TOTAL LIABILITIES
Total Short-Term Liabilities	$77.32M	$77.32M
Total Long-Term Liabilities	$473.9M	$473.9M
Total Liabilities	$551.2M	$551.2M
YoY Change	273.13%	273.13%
SHAREHOLDERS EQUITY
Retained Earnings	-$37.59M
YoY Change	-114009.09%
Common Stock	$657.1M
YoY Change	30.04%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$619.5M	$619.5M
YoY Change
Total Liabilities & Shareholders Equity	$1.171B	$1.171B
YoY Change	79.26%	79.26%

Cashflow Statement

Concept	2022 Q4	2022
OPERATING ACTIVITIES
Net Income	$10.43M	-$37.80M
YoY Change	-393.42%	466.23%
Depreciation, Depletion And Amortization	$7.181M	$21.72M
YoY Change	18.3%	675.68%
Cash From Operating Activities	-$28.40M	-$68.22M
YoY Change	88.69%	185.95%
INVESTING ACTIVITIES
Capital Expenditures	$2.588M	$7.450M
YoY Change	-166.27%	86.72%
Acquisitions
YoY Change
Other Investing Activities	-$54.95M	-$55.05M
YoY Change	383.54%	-82.22%
Cash From Investing Activities	-$57.53M	-$62.50M
YoY Change	276.82%	-80.26%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$0.00	$0.00
YoY Change		-100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	74.25M	124.4M
YoY Change	-3456.65%	-67.55%
NET CHANGE
Cash From Operating Activities	-28.40M	-68.22M
Cash From Investing Activities	-57.53M	-62.50M
Cash From Financing Activities	74.25M	124.4M
Net Change In Cash	-11.69M	-6.290M
YoY Change	-64.07%	-114.63%
FREE CASH FLOW
Cash From Operating Activities	-$28.40M	-$68.22M
Capital Expenditures	$2.588M	$7.450M
Free Cash Flow	-$30.99M	-$75.67M
YoY Change	177.99%	171.73%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2021	us-gaap	Fair Value Recurring Basis Unobservable Input Reconciliation Liability Gain Loss Statement Of Income Extensible List FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList	http://fasb.org/us-gaap/2022#FairValueAdjustmentOfWarrants
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0001813914
CY2022	us-gaap	Fair Value Recurring Basis Unobservable Input Reconciliation Liability Gain Loss Statement Of Income Extensible List FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList	http://fasb.org/us-gaap/2022#FairValueAdjustmentOfWarrants
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2022	dei	Document Type DocumentType	10-K
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-12-31
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Entity File Number EntityFileNumber	001-39391
CY2022	dei	Entity Registrant Name EntityRegistrantName	CareMax, Inc.
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2022	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	85-0992224
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	1000 NW 57th Court
CY2022	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 400
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	Miami
CY2022	dei	Entity Address State Or Province EntityAddressStateOrProvince	FL
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	33126
CY2022	dei	City Area Code CityAreaCode	786
CY2022	dei	Local Phone Number LocalPhoneNumber	360-4768
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2022	dei	Entity Small Business EntitySmallBusiness	true
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2022	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2022	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2022	dei	Entity Shell Company EntityShellCompany	false
CY2022Q2	dei	Entity Public Float EntityPublicFloat	222670146
CY2022	dei	Auditor Name AuditorName	WithumSmith+Brown, PC
CY2022	dei	Auditor Location AuditorLocation	Red Bank, New Jersey
CY2022	dei	Auditor Firm AuditorFirmId	100
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	41626000
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	47917000
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	151036000
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	41998000
CY2022Q4	us-gaap	Inventory Net InventoryNet	723000
CY2021Q4	us-gaap	Inventory Net InventoryNet	550000
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	3245000
CY2021Q4	us-gaap	Other Assets Current OtherAssetsCurrent	3786000
CY2022Q4	cmax	Risk Settlements Due From Providers Current RiskSettlementsDueFromProvidersCurrent	707000
CY2021Q4	cmax	Risk Settlements Due From Providers Current RiskSettlementsDueFromProvidersCurrent	539000
CY2022Q4	us-gaap	Assets Current AssetsCurrent	197336000
CY2021Q4	us-gaap	Assets Current AssetsCurrent	94790000
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	21006000
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	15993000
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	108937000
CY2022Q4	us-gaap	Goodwill Goodwill	700643000
CY2021Q4	us-gaap	Goodwill Goodwill	464566000
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	123585000
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	59811000
CY2022Q4	us-gaap	Deferred Costs DeferredCosts	1685000
CY2021Q4	us-gaap	Deferred Costs DeferredCosts	1972000
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	17550000
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	15960000
CY2022Q4	us-gaap	Assets Assets	1170743000
CY2021Q4	us-gaap	Assets Assets	653092000
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	7687000
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	3110000
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	18631000
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	8690000
CY2022Q4	cmax	Risk Settlement Liabilities Current RiskSettlementLiabilitiesCurrent	14171000
CY2021Q4	cmax	Risk Settlement Liabilities Current RiskSettlementLiabilitiesCurrent	196000
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	70000000
CY2021	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0
CY2022	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	13165000
CY2021	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	1522000
CY2022	us-gaap	Operating Expenses OperatingExpenses	743297000
CY2021	us-gaap	Operating Expenses OperatingExpenses	324585000
CY2022Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	30277000
CY2022Q4	cmax	Third Party Debt Current ThirdPartyDebtCurrent	253000
CY2021Q4	cmax	Third Party Debt Current ThirdPartyDebtCurrent	6275000
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	5512000
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	790000
CY2021Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	3687000
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	77322000
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	21959000
CY2022Q4	us-gaap	Shares Subject To Mandatory Redemption Settlement Terms Fair Value Of Shares SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares	3974000
CY2021Q4	us-gaap	Shares Subject To Mandatory Redemption Settlement Terms Fair Value Of Shares SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares	8375000
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	230725000
CY2021Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	110960000
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	96539000
CY2022Q4	us-gaap	Asset Acquisition Contingent Consideration Liability Noncurrent AssetAcquisitionContingentConsiderationLiabilityNoncurrent	134561000
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	8075000
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	6428000
CY2022Q4	us-gaap	Liabilities Liabilities	551196000
CY2021Q4	us-gaap	Liabilities Liabilities	147722000
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	1
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	1
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	11000
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	9000
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	657126000
CY2021Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	505327000
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-37590000
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	33000
CY2022Q4	us-gaap	Limited Liability Company Llc Members Equity Including Portion Attributable To Noncontrolling Interest LimitedLiabilityCompanyLlcMembersEquityIncludingPortionAttributableToNoncontrollingInterest	619547000
CY2021Q4	us-gaap	Limited Liability Company Llc Members Equity Including Portion Attributable To Noncontrolling Interest LimitedLiabilityCompanyLlcMembersEquityIncludingPortionAttributableToNoncontrollingInterest	505370000
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1170743000
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	653092000
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	631132000
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	295762000
CY2022	cmax	Health Care Organization External Provider Costs HealthCareOrganizationExternalProviderCosts	424182000
CY2021	cmax	Health Care Organization External Provider Costs HealthCareOrganizationExternalProviderCosts	206747000
CY2022	us-gaap	Health Care Organization Expenses Net HealthCareOrganizationExpensesNet	126648000
CY2021	us-gaap	Health Care Organization Expenses Net HealthCareOrganizationExpensesNet	57566000
CY2022	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	11761000
CY2021	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	4955000
CY2022	cmax	Corporate General And Administrative CorporateGeneralAndAdministrative	75824000
CY2021	cmax	Corporate General And Administrative CorporateGeneralAndAdministrative	40579000
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	21719000
CY2021	us-gaap	Depreciation And Amortization DepreciationAndAmortization	13216000
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-112165000
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-28822000
CY2021	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	866000
CY2022	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-20242000
CY2021	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-4492000
CY2022	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-4401000
CY2021	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-20757000
CY2022	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-76295000
CY2021	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-5794000
CY2022	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	0
CY2021	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-50000
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-6172000
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	1630000
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	546000
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1333000
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-57337000
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-6516000
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-19542000
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	159000
CY2022	us-gaap	Profit Loss ProfitLoss	-37796000
CY2021	us-gaap	Profit Loss ProfitLoss	-6675000
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	90799308
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	52620980
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	90799308
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	52620980
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.42
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.13
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.42
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.13
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	6727000
CY2021	cmax	Net Income Loss Prior To Business Combination NetIncomeLossPriorToBusinessCombination	-5185000
CY2021	cmax	Net Income Loss After Business Combination NetIncomeLossAfterBusinessCombination	-1490000
CY2021	cmax	Stock Issued During Period Value For Contingent Issuable Stock Upon First Share Price Trigger On Earnout Shares StockIssuedDuringPeriodValueForContingentIssuableStockUponFirstSharePriceTriggerOnEarnoutShares	39110000
CY2021	cmax	Additional Paid In Capital Adjustments Related Reclassification Of Contingent Consideration Previously Liability Classified AdditionalPaidInCapitalAdjustmentsRelatedReclassificationOfContingentConsiderationPreviouslyLiabilityClassified	45088000
CY2021	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	6650000
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1341000
CY2021	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	12883000
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	505370000
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	10271000
CY2022	cmax	Stock Cancelled During Period Value Held In Escrow StockCancelledDuringPeriodValueHeldInEscrow	-481000
CY2022	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	7590000
CY2022	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	173000
CY2022	us-gaap	Profit Loss ProfitLoss	-37796000
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	619547000
CY2022	us-gaap	Profit Loss ProfitLoss	-37796000
CY2021	us-gaap	Profit Loss ProfitLoss	-6675000
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	21719000
CY2021	us-gaap	Depreciation And Amortization DepreciationAndAmortization	13216000
CY2022	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	2382000
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	10271000
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	1341000
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-19542000
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	159000
CY2022	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-4401000
CY2021	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-20757000
CY2022	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-76295000
CY2021	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-5794000
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-6172000
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	1630000
CY2022	us-gaap	Paid In Kind Interest PaidInKindInterest	5277000
CY2021	us-gaap	Paid In Kind Interest PaidInKindInterest	0
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1243000
CY2021	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	0
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	70000000
CY2021	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0
CY2022	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-853000
CY2021	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-172000
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	66561000
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	3836000
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	172000
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	85000
CY2022	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-2678000
CY2021	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	768000
CY2022	cmax	Increase Decrease In Risk Settlement Assets And Liabilities IncreaseDecreaseInRiskSettlementAssetsAndLiabilities	-6775000
CY2021	cmax	Increase Decrease In Risk Settlement Assets And Liabilities IncreaseDecreaseInRiskSettlementAssetsAndLiabilities	459000
CY2022	cmax	Increase Decrease In Due To From Related Parties IncreaseDecreaseInDueToFromRelatedParties	0
CY2021	cmax	Increase Decrease In Due To From Related Parties IncreaseDecreaseInDueToFromRelatedParties	235000
CY2022	cmax	Increase Decrease In Other Operating Assets Excluding Other Current Assets IncreaseDecreaseInOtherOperatingAssetsExcludingOtherCurrentAssets	3127000
CY2021	cmax	Increase Decrease In Other Operating Assets Excluding Other Current Assets IncreaseDecreaseInOtherOperatingAssetsExcludingOtherCurrentAssets	1501000
CY2022	cmax	Increase Decrease In Operating Lease Assets And Liabilities IncreaseDecreaseInOperatingLeaseAssetsAndLiabilities	4386000
CY2021	cmax	Increase Decrease In Operating Lease Assets And Liabilities IncreaseDecreaseInOperatingLeaseAssetsAndLiabilities	0
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	1730000
CY2021	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-984000
CY2022	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	4722000
CY2021	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	1216000
CY2022	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	1470000
CY2021	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	1429000
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-68216000
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-23856000
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	7450000
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	3990000
CY2022	cmax	Proceeds From Return Of Escrowed Funds Relating To Acquisitions ProceedsFromReturnOfEscrowedFundsRelatingToAcquisitions	785000
CY2021	cmax	Proceeds From Return Of Escrowed Funds Relating To Acquisitions ProceedsFromReturnOfEscrowedFundsRelatingToAcquisitions	0
CY2022	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	55837000
CY2021	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	312589000
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-62502000
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-316579000
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	415000000
CY2022	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	0
CY2021	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	12471000
CY2022	cmax	Recapitalization Transaction RecapitalizationTransaction	0
CY2021	cmax	Recapitalization Transaction RecapitalizationTransaction	108435000
CY2022	cmax	Proceeds From Third Party Borrowings ProceedsFromThirdPartyBorrowings	229241000
CY2021	cmax	Proceeds From Third Party Borrowings ProceedsFromThirdPartyBorrowings	125000000
CY2022	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	29876000
CY2021	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	0
CY2022	cmax	Principal Payments On Long Term Debt PrincipalPaymentsOnLongTermDebt	121977000
CY2021	cmax	Principal Payments On Long Term Debt PrincipalPaymentsOnLongTermDebt	27711000
CY2022	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	7272000
CY2021	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	7478000
CY2022	us-gaap	Payments Of Debt Extinguishment Costs PaymentsOfDebtExtinguishmentCosts	0
CY2021	us-gaap	Payments Of Debt Extinguishment Costs PaymentsOfDebtExtinguishmentCosts	487000
CY2022	cmax	Collateral For Letters Of Credit CollateralForLettersOfCredit	5439000
CY2021	cmax	Collateral For Letters Of Credit CollateralForLettersOfCredit	0
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	124428000
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	383418000
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-6290000
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	42983000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	47917000
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4934000
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	41626000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	47917000
CY2022	cmax	Equity Warrant Consideration Issued EquityWarrantConsiderationIssued	7590000
CY2021	cmax	Equity Warrant Consideration Issued EquityWarrantConsiderationIssued	14533000
CY2022	us-gaap	Business Combination Consideration Transferred Equity Interests Issued And Issuable BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable	134420000
CY2021	us-gaap	Business Combination Consideration Transferred Equity Interests Issued And Issuable BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable	188678000
CY2022	cmax	Contingent Consideration Issued In Business Combination ContingentConsiderationIssuedInBusinessCombination	210856000
CY2021	cmax	Contingent Consideration Issued In Business Combination ContingentConsiderationIssuedInBusinessCombination	38348000
CY2022	cmax	Payroll Protection Program Loan Forgiveness PayrollProtectionProgramLoanForgiveness	0
CY2021	cmax	Payroll Protection Program Loan Forgiveness PayrollProtectionProgramLoanForgiveness	2164000
CY2022	cmax	Additions To Construction In Progress Funded Through Accounts Payable AdditionsToConstructionInProgressFundedThroughAccountsPayable	2847000
CY2021	cmax	Additions To Construction In Progress Funded Through Accounts Payable AdditionsToConstructionInProgressFundedThroughAccountsPayable	0
CY2022	cmax	Cancellation Of Escrowed Shares Related To Acquisitions CancellationOfEscrowedSharesRelatedToAcquisitions	821000
CY2021	cmax	Cancellation Of Escrowed Shares Related To Acquisitions CancellationOfEscrowedSharesRelatedToAcquisitions	0
CY2022	cmax	Accrued Purchase Consideration AccruedPurchaseConsideration	1225000
CY2021	cmax	Accrued Purchase Consideration AccruedPurchaseConsideration	0
CY2022	cmax	Financed Equipment Purchases FinancedEquipmentPurchases	607000
CY2021	cmax	Financed Equipment Purchases FinancedEquipmentPurchases	0
CY2022	us-gaap	Interest Paid Net InterestPaidNet	12797000
CY2021	us-gaap	Interest Paid Net InterestPaidNet	4423000
CY2022	cmax	Number Of Centers Operated And Managed NumberOfCentersOperatedAndManaged	62
CY2022	cmax	Affiliated Providers In Number Of States AffiliatedProvidersInNumberOfStates	10
CY2022	us-gaap	Use Of Estimates UseOfEstimates	<p style="text-indent:0.0%;font-size:10.0pt;margin-top:11.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">Use of Estimates</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">The areas where significant estimates are used in the accompanying financial statements include, but are not limited to, revenues and related receivables from risk adjustments, medical services expense and related payables, purchase price allocations, including fair value estimates of intangibles and contingent consideration, the valuation and related impairment testing of long-lived assets, including goodwill and intangible assets, the valuation of derivative warrant liabilities, and the estimated useful lives of fixed assets and intangible assets, including internally developed software. Actual results could differ from those estimates.</span></p>
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	1200000
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0
CY2022	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">Concentration of Credit Risk and Significant Customers</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">Financial instruments that potentially subject the Company to concentration of credit risk consist of cash, cash equivalents and accounts receivable. The Company’s cash balances with individual banking institutions are in excess of federally insured limits from time to time. The Company believes it is not exposed to any significant concentrations of credit risk from these financial instruments. The Company has not experienced any losses on its deposits of cash and cash equivalents.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;"> </span></p><div style="font-size:11.0pt;font-family:"Calibri", sans-serif;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">Composition of the Company's revenues and accounts receivable balances for the payors comprising 10% or more of revenue was as follows:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:46.065%;"/> <td style="width:25.472%;"/> <td style="width:3.0%;"/> <td style="width:25.463%;"/> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:"Calibri", sans-serif;min-width:fit-content;"> </span></p></td> <td colspan="3" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">Total Revenue</span></p></td> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:"Calibri", sans-serif;min-width:fit-content;"> </span></p></td> <td colspan="3" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">Years Ended December 31,</span></p></td> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:"Times New Roman", serif;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">2022</span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:"Times New Roman", serif;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">2021</span></p></td> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">Payor A</span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:8.0pt;font-family:"Times New Roman", serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">29</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">%</span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:"Times New Roman", serif;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:8.0pt;font-family:"Times New Roman", serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">48</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">%</span></p></td> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">Payor B</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:8.0pt;font-family:"Times New Roman", serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">18</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">%</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:"Times New Roman", serif;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">n/a</span></p></td> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">Payor C</span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:8.0pt;font-family:"Times New Roman", serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">18</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">%</span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:"Times New Roman", serif;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">n/a</span></p></td> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">Payor D</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:8.0pt;font-family:"Times New Roman", serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">14</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">%</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:"Times New Roman", serif;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">n/a</span></p></td> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">Payor E</span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:8.0pt;font-family:"Times New Roman", serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">14</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">%</span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:"Times New Roman", serif;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">n/a</span></p></td> </tr> </table><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:46.065%;"/> <td style="width:25.472%;"/> <td style="width:3.0%;"/> <td style="width:25.463%;"/> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:"Calibri", sans-serif;min-width:fit-content;"> </span></p></td> <td colspan="3" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">Accounts Receivable, net</span></p></td> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:"Calibri", sans-serif;min-width:fit-content;"> </span></p></td> <td colspan="3" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">Years Ended December 31,</span></p></td> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:"Times New Roman", serif;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">2022</span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:"Times New Roman", serif;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">2021</span></p></td> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">Payor A</span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:8.0pt;font-family:"Times New Roman", serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">13</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">%</span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:"Times New Roman", serif;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:8.0pt;font-family:"Times New Roman", serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">27</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">%</span></p></td> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">Payor B</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:8.0pt;font-family:"Times New Roman", serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">11</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">%</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:"Times New Roman", serif;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">n/a</span></p></td> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">Payor C</span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:8.0pt;font-family:"Times New Roman", serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">13</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">%</span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:"Times New Roman", serif;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">n/a</span></p></td> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">Payor D</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:8.0pt;font-family:"Times New Roman", serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">13</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">%</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:"Times New Roman", serif;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">n/a</span></p></td> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">Payor E</span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:8.0pt;font-family:"Times New Roman", serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">6</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">%</span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:"Times New Roman", serif;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">n/a</span></p></td> </tr> </table></div>
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	70000000.0
CY2022	us-gaap	Lessee Operating Lease Existence Of Option To Extend LesseeOperatingLeaseExistenceOfOptionToExtend	true
CY2022	us-gaap	Lessee Operating Lease Existence Of Option To Terminate LesseeOperatingLeaseExistenceOfOptionToTerminate	true
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0
CY2022	cmax	Reinsurance Premium Expense Incurred ReinsurancePremiumExpenseIncurred	19400000
CY2021	cmax	Reinsurance Premium Expense Incurred ReinsurancePremiumExpenseIncurred	10900000
CY2022	cmax	Reinsurance Recoveries Recognized ReinsuranceRecoveriesRecognized	27800000
CY2021	cmax	Reinsurance Recoveries Recognized ReinsuranceRecoveriesRecognized	14700000
CY2020Q4	us-gaap	Goodwill Goodwill	10068000
CY2021	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	454498000
CY2021Q4	us-gaap	Goodwill Goodwill	464566000
CY2022	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	307062000
CY2022	us-gaap	Goodwill Purchase Accounting Adjustments GoodwillPurchaseAccountingAdjustments	985000
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	70000000
CY2022Q4	us-gaap	Goodwill Goodwill	700643000
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	70000000.0
CY2022Q4	us-gaap	Goodwill Impaired Accumulated Impairment Loss GoodwillImpairedAccumulatedImpairmentLoss	70000000.0
CY2021Q4	us-gaap	Goodwill Impaired Accumulated Impairment Loss GoodwillImpairedAccumulatedImpairmentLoss	0
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	151695000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	28109000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	123585000
CY2021Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	71141000
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	11331000
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	59811000
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	16800000
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	10400000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	21406000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	19422000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	17871000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	16451000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	12905000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	35530000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	123585000
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	31620000
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	21902000
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	10614000
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	5909000
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	21006000
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	15993000
CY2022	us-gaap	Depreciation Depreciation	4900000
CY2021	us-gaap	Depreciation Depreciation	2800000
CY2022Q2	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	300000000
CY2022Q2	us-gaap	Repayments Of Debt RepaymentsOfDebt	121000000
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-6200000
CY2022	us-gaap	Debt Instrument Interest Rate Terms DebtInstrumentInterestRateTerms	Based on the elections made by the Company, as of December 31, 2022, borrowings under the Credit Agreement bore interest of Term SOFR (calculated as the Secured Overnight Financing Rate published on the Federal Reserve Bank of New York’s website, plus the applicable credit spread adjustment based on the elected interest period), plus an applicable margin rate of 9.00%. As permitted under the Credit Agreement, the Company elected to capitalize 4.00% of the interest as principal amount. As a result of this election, the cash interest component of the applicable margin increased by 0.50%.
CY2022	cmax	Percentage Of Debt Interest Capitalized As Principal Amount Outstanding PercentageOfDebtInterestCapitalizedAsPrincipalAmountOutstanding	0.0400
CY2022	cmax	Debt Instrument Increase In Applicable Margin Rate DebtInstrumentIncreaseInApplicableMarginRate	0.0050
CY2022	cmax	Debt Instrument Maturity Month And Year DebtInstrumentMaturityMonthAndYear	2027-05
CY2022	us-gaap	Debt Instrument Covenant Description DebtInstrumentCovenantDescription	The Credit Agreement also contains covenants that require the Company to satisfy a minimum liquidity requirement of $50.0 million, which may be decreased to $25.0 million if the Company achieves a certain adjusted EBITDA, and maintain a maximum total leverage ratio based on the Company’s consolidated EBITDA, as defined in the Credit Agreement, with de novo losses excluded from the calculation of such ratio for up to 36 months after the opening of a de novo center, which maximum total leverage ratio will initially be 8.50 to 1.00, commencing with the fiscal quarter ended September 30, 2022 and is subject to a series of step-downs. For the fiscal quarters ending September 30, 2026 and thereafter the Company must maintain a maximum total leverage ratio no greater than 5.50 to 1.00.
CY2022Q2	cmax	Debt Instrument Covenant Minimum Liquidity Requirement DebtInstrumentCovenantMinimumLiquidityRequirement	50000000.0
CY2022Q2	cmax	Debt Instrument Covenant Minimum Liquidity Requirement Reduced Amount On Achieving Adjusted Ebitda DebtInstrumentCovenantMinimumLiquidityRequirementReducedAmountOnAchievingAdjustedEbitda	25000000.0
CY2022Q2	cmax	De Novo Losses Excluded From Calculation Of Such Ratio Period DeNovoLossesExcludedFromCalculationOfSuchRatioPeriod	P36M
CY2022Q2	cmax	Debt Instrument Covenants Maximum Leverage Ratio DebtInstrumentCovenantsMaximumLeverageRatio	8.50
CY2022Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	35500000
CY2022Q4	cmax	Debt Instrument Debt Default Percentage DebtInstrumentDebtDefaultPercentage	0.040
CY2022Q4	us-gaap	Debt Instrument Interest Rate Increase Decrease DebtInstrumentInterestRateIncreaseDecrease	0.050
CY2022Q4	us-gaap	Repayment Of Notes Receivable From Related Parties RepaymentOfNotesReceivableFromRelatedParties	6800000
CY2022Q4	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	16188000
CY2021Q4	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	4704000
CY2022Q4	us-gaap	Long Term Debt LongTermDebt	261256000
CY2021Q4	us-gaap	Long Term Debt LongTermDebt	117236000
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	30530000
CY2021Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	6275000
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	230725000
CY2021Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	110960000
CY2022Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	35763000
CY2022Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	1660000
CY2022Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	2599000
CY2022Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	2591000
CY2022Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	2576000
CY2022Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	232255000
CY2022Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	277444000
CY2021Q2	cmax	Capital Stock Par Or Stated Value Per Share CapitalStockParOrStatedValuePerShare	0.0001
CY2021Q2	us-gaap	Capital Units Authorized CapitalUnitsAuthorized	261000000
CY2021Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	260000000
CY2021Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000
CY2022	us-gaap	Preferred Stock Voting Rights PreferredStockVotingRights	In any such vote, the share of Series A Preferred Stock will be entitled to 37,241,783 votes
CY2021Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	131000
CY2021Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	5.82
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	286332
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	6.13
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	43767
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue	5.82
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	373565
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	6.06
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	10300000
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	1300000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-37796000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-6675000
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	90799308
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	52620980
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	90799308
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	52620980
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.42
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.13
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.42
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.13
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	57747594
CY2021	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	18163652
CY2022	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	4400000
CY2021	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	20800000
CY2022Q4	us-gaap	Asset Acquisition Contingent Consideration Liability Noncurrent AssetAcquisitionContingentConsiderationLiabilityNoncurrent	134600000
CY2022Q4	cmax	Contingent Earnout Shares Payable ContingentEarnoutSharesPayable	37500000
CY2022	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Out Of Level3 FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3	0
CY2022	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Into Level3 FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3	0
CY2022	cmax	Fair Value Liabilities Level1 To Level2 Transfers Amount1 FairValueLiabilitiesLevel1ToLevel2TransfersAmount1	0
CY2022	cmax	Fair Value Liabilities Level2 To Level1 Transfers Amount1 FairValueLiabilitiesLevel2ToLevel1TransfersAmount1	0
CY2021	cmax	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Warrants Issued FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityWarrantsIssued	29132000
CY2021	cmax	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Contingent Consideration Issued FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationIssued	875000
CY2021	cmax	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Fair Value Adjustment Of Warrants FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityFairValueAdjustmentOfWarrants	-20757000
CY2021Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	9250000
CY2022	cmax	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Fair Value Adjustment Of Warrants FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityFairValueAdjustmentOfWarrants	-4401000
CY2022	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements	875000
CY2022	cmax	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Contingent Consideration FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsideration	210856000
CY2022	cmax	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Fair Value Adjustment Of Contingent Consideration FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityFairValueAdjustmentOfContingentConsideration	-76295000
CY2022Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	138535000
CY2022	cmax	Lessee Operating Lease Expiring Term Description LesseeOperatingLeaseExpiringTermDescription	various times through 2043
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	13769000
CY2022	us-gaap	Variable Lease Cost VariableLeaseCost	1897000
CY2022	us-gaap	Short Term Lease Cost ShortTermLeaseCost	1145000
CY2022	us-gaap	Lease Cost LeaseCost	16810000
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	44200000
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	9400000
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P11Y
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0633
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	10508000
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	14522000
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	13760000
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	12869000
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	12090000
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	83944000
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	147693000
CY2022Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	46116000
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	101577000
CY2022Q4	cmax	Operating Lease Not Yet Commenced Aggregate Estimated Future Lease Payments OperatingLeaseNotYetCommencedAggregateEstimatedFutureLeasePayments	103000000.0
CY2021	us-gaap	Operating Lease Expense OperatingLeaseExpense	7200000
CY2021Q4	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	10087000
CY2021Q4	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	10028000
CY2021Q4	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	9715000
CY2021Q4	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	9374000
CY2021Q4	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	8685000
CY2021Q4	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	58763000
CY2021Q4	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	106652000
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-15536000
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	126000
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-4006000
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	33000
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-19542000
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	159000
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.077
CY2021	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.049
CY2022	cmax	Effective Income Tax Rate Reconciliation Transaction Costs Percent EffectiveIncomeTaxRateReconciliationTransactionCostsPercent	0.022
CY2021	cmax	Effective Income Tax Rate Reconciliation Transaction Costs Percent EffectiveIncomeTaxRateReconciliationTransactionCostsPercent	0.142
CY2022	cmax	Effective Income Tax Rate Reconciliation Earnout Liability Adjustments EffectiveIncomeTaxRateReconciliationEarnoutLiabilityAdjustments	0.279
CY2021	cmax	Effective Income Tax Rate Reconciliation Earnout Liability Adjustments EffectiveIncomeTaxRateReconciliationEarnoutLiabilityAdjustments	0.000
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Amortization EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAmortization	0.172
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Amortization EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAmortization	0.000
CY2022	cmax	Effective Income Tax Rate Reconciliation Paycheck Protection Program Loan Forgiveness Percent EffectiveIncomeTaxRateReconciliationPaycheckProtectionProgramLoanForgivenessPercent	0.000
CY2021	cmax	Effective Income Tax Rate Reconciliation Paycheck Protection Program Loan Forgiveness Percent EffectiveIncomeTaxRateReconciliationPaycheckProtectionProgramLoanForgivenessPercent	0.081
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	0.002
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	0.002
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.029
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.221
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.341
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.025
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	6738000
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	2257000
CY2022Q4	us-gaap	Deferred Tax Assets Derivative Instruments DeferredTaxAssetsDerivativeInstruments	1053000
CY2021Q4	us-gaap	Deferred Tax Assets Derivative Instruments DeferredTaxAssetsDerivativeInstruments	2219000
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	24184000
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	15982000
CY2022Q4	cmax	Deferred Tax Assets Business Expense Limitation DeferredTaxAssetsBusinessExpenseLimitation	11682000
CY2021Q4	cmax	Deferred Tax Assets Business Expense Limitation DeferredTaxAssetsBusinessExpenseLimitation	6962000
CY2022Q4	cmax	Deferred Tax Assets Lease Liabilities DeferredTaxAssetsLeaseLiabilities	27033000
CY2022Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	312000
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	71002000
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	27420000
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	25793000
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	26128000
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	45209000
CY2021Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	1292000
CY2022Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	18524000
CY2021Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	1480000
CY2021Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	18000
CY2022Q4	us-gaap	Deferred Tax Liabilities Prepaid Expenses DeferredTaxLiabilitiesPrepaidExpenses	7000
CY2021Q4	us-gaap	Deferred Tax Liabilities Prepaid Expenses DeferredTaxLiabilitiesPrepaidExpenses	219000
CY2022Q4	cmax	Deferred Tax Liabilities Right Of Use Lease Assets DeferredTaxLiabilitiesRightOfUseLeaseAssets	28868000
CY2022Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	47399000
CY2021Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	1717000
CY2022Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	2190000
CY2021Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	425000
CY2022	cmax	Decrease In Income Tax Valuation Allowance DecreaseInIncomeTaxValuationAllowance	300000
CY2021Q2	cmax	Operating Loss Carryforwards Subject To Limitation OperatingLossCarryforwardsSubjectToLimitation	43900000
CY2021Q2	cmax	Operating Loss Carryforwards Subject To Business Expense Limitation OperatingLossCarryforwardsSubjectToBusinessExpenseLimitation	21900000
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0

Files In Submission

Name	View Source	Status
0000950170-23-011018-index-headers.html	Edgar Link	pending
0000950170-23-011018-index.html	Edgar Link	pending
0000950170-23-011018.txt	Edgar Link	pending
0000950170-23-011018-xbrl.zip	Edgar Link	pending
cmax-20221231.htm	Edgar Link	pending
cmax-20221231.xsd	Edgar Link	pending
cmax-ex21_1.htm	Edgar Link	pending
cmax-ex23_1.htm	Edgar Link	pending
cmax-ex23_2.htm	Edgar Link	pending
cmax-ex31_1.htm	Edgar Link	pending
cmax-ex31_2.htm	Edgar Link	pending
cmax-ex32_1.htm	Edgar Link	pending
cmax-ex32_2.htm	Edgar Link	pending
cmax-ex4_4.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
img230359145_0.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
cmax-20221231_cal.xml	Edgar Link	unprocessable
cmax-20221231_def.xml	Edgar Link	unprocessable
cmax-20221231_lab.xml	Edgar Link	unprocessable
cmax-20221231_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
cmax-20221231_htm.xml	Edgar Link	completed
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CMAXQ
CareMax, Inc. Stock $cmaxq

2022 Q4 Form 10-K Financial Statement

#000095017023011018 Filed on March 30, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CMAXQ CareMax, Inc. Stock $cmaxq

2022 Q4 Form 10-K Financial Statement

#000095017023011018 Filed on March 30, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CMAXQ
CareMax, Inc. Stock $cmaxq